0001562180-22-006294.txt : 20220823 0001562180-22-006294.hdr.sgml : 20220823 20220823200258 ACCESSION NUMBER: 0001562180-22-006294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220819 FILED AS OF DATE: 20220823 DATE AS OF CHANGE: 20220823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marks Jason M. CENTRAL INDEX KEY: 0001878953 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 221188628 MAIL ADDRESS: STREET 1: C/O AMARIN PHARMA, INC. STREET 2: 440 US HIGHWAY 22 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-08-19 false 0000897448 AMARIN CORP PLC\UK AMRN 0001878953 Marks Jason M. C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 false true false false EVP,Chief Global Legal Officer Ordinary Shares 2022-08-19 4 M false 33334.00 A 33334.00 D Ordinary Shares 2022-08-19 4 F false 11417.00 1.60 D 21917.00 D Restricted Stock Units 0.00 2022-08-19 4 M false 33334.00 0.00 D Ordinary Shares 33334.00 66666.00 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. On September 1, 2021, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. These RSUs vest in three equal installments on each of August 19, 2022, August 19, 2023 and August 19, 2024. The first vesting event occurred on August 19, 2022. Not applicable. Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Please see the section titled "Remarks" below for additional information. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. In the case of a Change of Control (as defined in the Issuer's stock incentive plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 746,583 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time. /s/ Jason M. Marks 2022-08-23